![]() ![]() ML元 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. doi: 10.1016/j.molcel.2014.12.034.Ĭhen C, Liu Yu, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Ye P*, Liu Yu*, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. Identifying a confused cell identity for esophageal squamous cell carcinoma. Pan X, Wang J, Guo L, Na F, Du J, Chen X, Zhong A, Zhao L, Zhang L, Zhang M, Wan X, Wang M, Liu H, Dai S, Tan P, Chen J, Liu Yu#, Hu B#, Chen C#. Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy. Wu B, Pan X, Chen X, Chen M, Shi K, Xu J, Zheng J, Niu T, Chen C#, Shuai X#, Liu Yu#. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Liu P*, Pan X*, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, Wu Y, Liu Yu#, Liu T#. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Liu Yu*, Chen C*, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, Levine RL, Mills AA, Lowe SW. An Epigenetic Mechanism Underlying Chromosome 17p Deletion-Driven Tumorigenesis. 2022 Sep 12 40(9):1044-1059.e8.Ĭhen M*, Chen X*, Li S, Pan X, Gong Y, Zheng J, Xu J, Zhao C, Zhang Q, Zhang S, Qi L, Wang Z, Shi K, Ding BS, Xue Z, Chen L, Yang S, Wang Y, Niu T, Dai L, Lowe SW, Chen C#, Liu Yu#. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. In 2020, she played 17 events and made 12 cuts, she also recorded 2 top-10 finishes including a season-best T4 result at the ISPS Handa Women’s Australian Open.Wang M#, Chen X#, Tan P#, Wang Y#, Pan X, Lin T, Jiang Y, Wang B, Xu H, Wang Y, Yang Y, Wang J, Zhao L, Zhang J, Zhong A, Peng Y, Du J, Zhang Q, Zheng J, Chen J, Dai S, Na F, Lu Z, Liu J, Zheng X, Yang L, Zhang P, Han P, Gong Q, Zhong Q, Xiao K, Yang H, Deng H, Zhao Y, Shi H, Man J, Gou M, Zhao C, Dai L, Xue Z, Chen L, Wang Y, Zeng M, Huang C, Wei Q*, Wei Y, Liu Y*, Chen C*. Women’s Open (T5) and the AIG Women’s British Open (T7). In 2019, Liu played 28 events and made 26 cuts, she recorded a career-best 7 top-10 finishes, including at the U.S. In 2017, Liu finished 5th on the Symetra Tour money list to earn LPGA membership for the 2018 season.ĭuring her rookie year 2018, she played 27 events and made 21 cuts, Liu recorded three top-10 finishes including a career-best major finish of T7 at the Ricoh Women’s British Open. Liu turned professional in 2015 and played on the Symetra Tour, where she earned victory at the Tullymore Classic. While there she was the ACC Rookie of the Year, she also won at the Darius Rucker Intercollegiate and earned victory at the 2013-14 national championship with Duke University. She attended the Duke University in Durham, North Carolina, where she played collegiate golf. Liu finished 1st at the 2012 Chongqing Challenge, after firing rounds of 72, 68, and 71, and was a runner-up at the 2012 CLPGA Srixon Ladies Open and the CLPGA China Unicom professional–amateur. As an amateur, Liu was a three-time winner on the AJGA circuit and was in the 2011 Second Team Rolex Junior All-America. She started playing golf at the age of 9 years old. Yu Liu is a Chinese professional golfer who plays on the LPGA Tour. ![]()
0 Comments
Leave a Reply. |